Screener
Denali Therapeutics Inc. DNLI Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $11,807 | $505 |
| Other accrued costs and current liabilities | 78,276 | 97,846 |
| Total current liabilities | 90,083 | 98,351 |
| Operating lease liability, less current portion | 22,026 | 27,210 |
| Finance lease liability, less current portion | 5,479 | 5,532 |
| Liability related to the revenue participation right agreement | 205,189 | — |
| Total liabilities | 322,777 | 131,093 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s total current liabilities?
- Denali Therapeutics Inc. (DNLI) reported total current liabilities of $90.08M in Q2 2026.
- How has Denali Therapeutics Inc.'s total current liabilities changed year-over-year?
- Denali Therapeutics Inc.'s total current liabilities decreased by 1.1% year-over-year, from $91.06M to $90.08M.
- What is the long-term trend for Denali Therapeutics Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s total current liabilities has grown at a 6.5% compound annual growth rate (CAGR), from $71.7M to $98.35M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Denali Therapeutics Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude